Skip to main content
Log in

Cardiac fibrosis

Targeting metabolically activated fibroblasts in the failing heart

  • News & Views
  • Published:

From Nature Cardiovascular Research

View current issue Submit your manuscript

Myofibroblast activation requires nuclear translocation of ATP citrate lyase (ACLY) that triggers chromatin remodeling and the induction of fibrosis-associated genes. ACLY inhibition prevents myofibroblast conversion and causes de-differentiation of myofibroblasts to fibroblasts, indicating a potential therapeutic approach for heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: ACLY stimulates cardiac fibrosis in heart failure.

References

  1. Humeres, C. et al. J. Clin. Invest. 132, e146926 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Gibb, A. A., Lazaropoulos, M. P. & Elrod, J. W. Circ. Res. 127, 427–447 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lombardi, A. A. et al. Nat. Commun. 10, 4509 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Lazaropoulos, M. P. et al. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-024-00502-3 (2024).

    Article  Google Scholar 

  5. Moussaieff, A. et al. Cell Metab. 21, 392–402 (2015).

    Article  CAS  PubMed  Google Scholar 

  6. Younesi, F. S., Miller, A. E., Barker, T. H., Rossi, F. M. V. & Hinz, B. Nat. Rev. Mol. Cell Biol. https://doi.org/10.1038/s41580-024-00716-0 (2024).

    Article  PubMed  Google Scholar 

  7. Li, Y. et al. J. Mol. Cell Cardiol. 171, 117–132 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Tallquist, M. D. Annu. Rev. Physiol. 82, 63–78 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. McLellan, M. A. et al. Circulation 142, 1448–1463 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Fu, X. et al. J. Clin. Invest. 128, 2127–2143 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

N.G.F.’s laboratory is supported by National Institutes of Health (NIH) grants R01 HL76246, R01 HL85440 and R01 HL149407, and by US Department of Defense grant PR211352.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nikolaos G. Frangogiannis.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frangogiannis, N.G. Targeting metabolically activated fibroblasts in the failing heart. Nat Cardiovasc Res 3, 782–784 (2024). https://doi.org/10.1038/s44161-024-00500-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-024-00500-5

  • Springer Nature Limited

Navigation